Decipher Labs
BSE: DECIPHER · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Decipher Labs's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Decipher Labs Limited is an Indian IT services company specialising in technology solutions for the healthcare and life sciences sectors. The firm provides software development, data management, and digital transformation services to streamline clinical research and pharmaceutical operations.
Business Model
The company generates revenue by providing specialised consulting and technology services to clients operating within the highly regulated medical and pharmaceutical industries.
Management Commentary
The company has transitioned from its historical identity as Combat Drugs Limited to focus on technology-driven healthcare solutions.
Growth Outlook
Growth is expected to be driven by leveraging domain expertise to support global clients seeking specialised IT solutions in the pharmaceutical and clinical research domains.
Key Risks
- Regulatory Compliance. The company faces significant risks related to the stringent regulatory requirements governing the pharmaceutical and healthcare data sectors.
- Market Competition. As a small-cap entity, the company faces intense competition from larger, well-established IT service providers with greater resources.
- Client Concentration. Reliance on a niche client base within the life sciences sector may lead to revenue volatility if key contracts are lost or delayed.
- Technological Obsolescence. The rapid pace of innovation in software and digital transformation requires continuous investment to remain relevant to global pharmaceutical clients.
Start your research today
Unlock AI insights, financials, peers and live data on Decipher Labs and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Decipher LabsDECIPHER | ₹6 Cr | — | — | — | -24.1% | — | — | -45.1% |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Mar 2026
Financials
Decipher Labs
BSE: DECIPHER · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Decipher Labs's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Decipher Labs Limited is an Indian IT services company specialising in technology solutions for the healthcare and life sciences sectors. The firm provides software development, data management, and digital transformation services to streamline clinical research and pharmaceutical operations.
Business Model
The company generates revenue by providing specialised consulting and technology services to clients operating within the highly regulated medical and pharmaceutical industries.
Management Commentary
The company has transitioned from its historical identity as Combat Drugs Limited to focus on technology-driven healthcare solutions.
Growth Outlook
Growth is expected to be driven by leveraging domain expertise to support global clients seeking specialised IT solutions in the pharmaceutical and clinical research domains.
Key Risks
- Regulatory Compliance. The company faces significant risks related to the stringent regulatory requirements governing the pharmaceutical and healthcare data sectors.
- Market Competition. As a small-cap entity, the company faces intense competition from larger, well-established IT service providers with greater resources.
- Client Concentration. Reliance on a niche client base within the life sciences sector may lead to revenue volatility if key contracts are lost or delayed.
- Technological Obsolescence. The rapid pace of innovation in software and digital transformation requires continuous investment to remain relevant to global pharmaceutical clients.
Start your research today
Unlock AI insights, financials, peers and live data on Decipher Labs and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026